Live

G

$GRCE

1 article found

1 positive

0 negative

0 neutral

Grace Therapeutics to Present at TD Cowen Conference; FDA Sets GTx-104 Review Date

GlobeNewswire Inc.

GlobeNewswire Inc.·Feb 25·Na

Grace Therapeutics to Present at TD Cowen Conference; FDA Sets GTx-104 Review Date

Grace Therapeutics will present at TD Cowen conference in March 2026. FDA sets April 2026 review date for GTx-104 aneurysmal subarachnoid hemorrhage treatment.

GRCEFDA approvalclinical-stage